Investing.com -- A new survey-based report headed by TD Cowen analyst Derrick Wood suggests artificial intelligence monetization is approaching an inflection point, with incumbent software vendors poised to benefit more than markets currently reflect.
Investing.com -- A new survey-based report headed by TD Cowen analyst Derrick Wood suggests artificial intelligence monetization is approaching an inflection point, with incumbent software vendors poised to benefit more than markets currently reflect.
We are selling 25 shares of Broadcom at roughly 418.57. Following the trade, Jim Cramer's Charitable Trust will own 365 shares of AVGO, decreasing its weighting in the portfolio to roughly 4% from 4.30%. Semiconductor stocks are having another strong day in the market, thanks to Intel's positive commentary about central processing unit (CPU) demand in the agentic AI era. The Philadelphia Stock Exc...
We are selling 25 shares of Broadcom at roughly 418.57. Following the trade, Jim Cramer's Charitable Trust will own 365 shares of AVGO, decreasing its weighting in the portfolio to roughly 4% from 4.30%. Semiconductor stocks are having another strong day in the market, thanks to Intel's positive commentary about central processing unit (CPU) demand in the agentic AI era. The Philadelphia Stock Exchange Semiconductor Index, also known as the SOX, has gone completely parabolic, extending its rally to an 18th straight session. It's climbed roughly 50% over that stretch. We're not trying to chase the chip stocks after a run of this magnitude. Instead, we're lightening up on some of our big positions, locking in hefty gains in the process. On Thursday, we trimmed our stake in Qnity Electronics , a critical materials supplier to the semiconductor industry. Around the time of our sale, Qnity's stock was up 78% year to date. Now on Friday, we're trimming our Broadcom position for the third time in the past two weeks. Although Broadcom isn't participating in Friday's rally, the stock is still on pace for another good week, with shares up about 2%. Broadcom has rallied roughly 5% from our previous sale on April 15. Jim said on our Monthly Meeting a week ago that he wanted to take more shares off on the next 5% move, and here we are. The cash raised for this sale will help support more buys of stocks that have fallen out of favor. The chips are taking a lot of oxygen in the market, which we are enjoying through numerous positions. However, the money coming out of other companies with strong outlooks could create opportunities to snap up more shares at attractive levels. From this Broadcom sale, we will realize a gain of 375% on stock purchased in September 2023. (Jim Cramer's Charitable Trust is long AVGO and Q. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits...
Pakistan purchased a liquefied natural gas shipment from the expensive spot market for the first time in over two years to ease a shortage caused by the conflict in the Middle East. Pakistan LNG Ltd. purchased an LNG shipment from TotalEnergies SE for April 27-30 delivery to Pakistan via a tender that closed on Friday, according to traders with knowledge of the matter. Pakistan opted not to buy tw...
Pakistan purchased a liquefied natural gas shipment from the expensive spot market for the first time in over two years to ease a shortage caused by the conflict in the Middle East. Pakistan LNG Ltd. purchased an LNG shipment from TotalEnergies SE for April 27-30 delivery to Pakistan via a tender that closed on Friday, according to traders with knowledge of the matter. Pakistan opted not to buy two other shipments it was seeking via the same tender, said the traders, who asked not to be identified because the information is not public. The move will help in an urgent effort to lift gas supply in Pakistan, which hasn’t received an LNG shipment since early-March because of the closure of the Strait of Hormuz. Pakistan procured nearly all of its LNG from Qatar last year. The gas shortage has triggered widespread power outages across Pakistan, posing a significant threat to the country’s economic growth. Four Qatari LNG shipments earmarked for Pakistan have been stuck in the Persian Gulf since the war began in late-February, according to ship-tracking data compiled by Bloomberg. Read More: A War in the Persian Gulf Is Plunging Pakistan Into Darkness TotalEnergies offered the shipment to Pakistan at $18.88 per million British thermal units, according to the traders. That’s more than double the price of a shipment from one of Pakistan’s long-term contract with Qatar, according to Bloomberg calculations. LNG prices in Asia are trading about 70% higher than pre-war levels as the halt to Hormuz has throttled about 20% of global supply of the fuel.
everydayplus/iStock via Getty Images Coverage on the Alerian MLP ETF ( AMLP ) has been generally bullish on Seeking Alpha. It is rated a Buy or Strong Buy because of its high yield, improved balance sheets, and structural tailwinds for midstream energy. This view is not without merit. However, there are gaps in that assessment that are easy to miss. The market prices AMLP today as an income vehicl...
everydayplus/iStock via Getty Images Coverage on the Alerian MLP ETF ( AMLP ) has been generally bullish on Seeking Alpha. It is rated a Buy or Strong Buy because of its high yield, improved balance sheets, and structural tailwinds for midstream energy. This view is not without merit. However, there are gaps in that assessment that are easy to miss. The market prices AMLP today as an income vehicle, not an undervalued equity. The yield is now near historical lows. The fund structure creates certain drags and caps upside. The gap between AMLP and risk-free instruments has narrowed. The risk-reward profile is not favorable. Forward returns are mostly coming from income. Even a small change in required yield can create downside. For these reasons, I consider AMLP a sell. Bull Case A recent bullish article by Thomas Carroll argues that AMLP is an underpriced midstream fund whose balance sheet is improving while cash flow remains durable. The bull case sets itself on three things—valuation discount, repaired fundamentals, and improving demand. The bull case begins with valuation. In that article, Carroll notes that AMLP trades at roughly 13.4x forward earnings. Since AMLP itself doesn’t have true earnings, he derives this using a weighted average of earnings of AMLP’s holdings. The article notes that "comparable" large-cap midstream C-corps trade closer to 24x, although the range for the 3 securities compared is high, from 15x to 33x. The implied discount cited is ~40% vs. the S&P 500 and a much larger 79% vs. midstream peers in the index. On a relative basis, AMLP’s yield is ~7.5-7.65%, whereas “comparable” midstream peers come in the ~3.5-5% range. This gives us the bull thesis—higher income plus lower multiple implies an undervalued income equity. A second part of the thesis is that fundamentals are becoming stronger, especially in terms of deleveraging across midstream assets. The bullish view points to the drop in net debt/EBITDA across AMLP’s holdings, from roughly...
HJBC/iStock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed five new medicines for approval this week, including an autoimmune drug from Sanofi ( SNY ), a rare disease therapy from Arrowhead Pharma ( ARWR ), and a gene therapy from Novartis ( NVS ). Sanofi Sanofi ( SNY ) announced on Friday that the EMA’s Committee for Medicinal Pr...
HJBC/iStock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed five new medicines for approval this week, including an autoimmune drug from Sanofi ( SNY ), a rare disease therapy from Arrowhead Pharma ( ARWR ), and a gene therapy from Novartis ( NVS ). Sanofi Sanofi ( SNY ) announced on Friday that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of Cenrifki, a treatment targeting an autoimmune disorder known as multiple sclerosis. Issuing a positive opinion, the CHMP has endorsed the oral Bruton’s tyrosine kinase inhibitor for patients with secondary progressive multiple sclerosis who have not experienced relapses over the last two years, the French drugmaker stated. The CHMP recommendation will next be reviewed by the European Commission (EC) for a final decision on marketing authorization expected in the coming months. Arrowhead Pharma Arrowhead Pharmaceuticals ( ARWR ) announced a positive opinion from the CHMP for its RNA (siRNA) medicine Redemplo (plozasiran) to reduce triglycerides in adults with familial chylomicronemia syndrome, a rare disease. The Pasadena, California-based biotech expects a final decision on the marketing authorization in Q2 2026. Novartis Novartis ( NVSEF ) announced on Friday that the CHMP recommended approval for its gene therapy, Itvisma, for patients with spinal muscular atrophy, a rare genetic neuromuscular disorder. The panel’s positive opinion endorses the one-time therapy for use in those aged two years and older with a specific type of spinal muscular atrophy. The company expects a final decision on the authorization in roughly two months. More on Sanofi, Novartis, etc. Sanofi (SAN:CA) Q1 2026 Earnings Call Transcript Sanofi 2026 Q1 - Results - Earnings Call Presentation Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade) WHO prequalifies Novartis’ Coartem Baby for infants Sanofi beats Q1 estimates; reaffirms FY...
Key PointsBridge Generations Wealth Management added 47,823 shares of DFGX during Q1 2026, an estimated $2.5 million transaction based on quarterly average pricing.
Key PointsBridge Generations Wealth Management added 47,823 shares of DFGX during Q1 2026, an estimated $2.5 million transaction based on quarterly average pricing.
Move will remove obstacle for confirmation of Kevin Warsh, Trump’s pick to replace Powell as Federal Reserve chair Sign up for the Breaking News US email to get newsletter alerts in your inbox The US Department of Justice is dropping its criminal investigation against Federal Reserve chair Jerome Powell , clearing the path for Donald Trump ’s new nominee for chair to be confirmed. Jeanine Pirro, T...
Move will remove obstacle for confirmation of Kevin Warsh, Trump’s pick to replace Powell as Federal Reserve chair Sign up for the Breaking News US email to get newsletter alerts in your inbox The US Department of Justice is dropping its criminal investigation against Federal Reserve chair Jerome Powell , clearing the path for Donald Trump ’s new nominee for chair to be confirmed. Jeanine Pirro, Trump’s appointed US attorney for the District of Columbia, said in a social media post that she directed her office to close its investigation into renovations at the Fed headquarters that went over budget. Continue reading...
The Guardian Australia picture editor, Carly Earl, explains why an official photo from the White House celebrating a champion women’s sports team has drawn backlash Continue reading...
The Guardian Australia picture editor, Carly Earl, explains why an official photo from the White House celebrating a champion women’s sports team has drawn backlash Continue reading...
Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the WisdomTree Bloomberg Floating Rate Treasury Fund, where 8,160,000 units were destroyed, or a 2.4% decrease week over week. And on a perce
Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the WisdomTree Bloomberg Floating Rate Treasury Fund, where 8,160,000 units were destroyed, or a 2.4% decrease week over week. And on a perce
Tesla's Cybercab is now in production at the company's Gigafactory in Austin, Texas, but Elon Musk is sounding unusually cautious about the rollout. The robotaxi's start of production was announced Thursday on X, with Tesla posting a video shot from inside a steering wheel-less Cybercab as it drove out of the factory with the caption, "Purpose built for autonomy." The company made a few initial Cy...
Tesla's Cybercab is now in production at the company's Gigafactory in Austin, Texas, but Elon Musk is sounding unusually cautious about the rollout. The robotaxi's start of production was announced Thursday on X, with Tesla posting a video shot from inside a steering wheel-less Cybercab as it drove out of the factory with the caption, "Purpose built for autonomy." The company made a few initial Cybercabs back in February , but continuous production only started this month. But with the company's robotaxi plans creeping along much slower than expected, many Tesla watchers are left scratching their heads about the future - especially as Mus … Read the full story at The Verge.
Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern speak daily with leaders and decision makers from Wall Street to Washington and beyond. No other program better positions investors and executives for the trading day. (Source: Bloomberg)
Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern speak daily with leaders and decision makers from Wall Street to Washington and beyond. No other program better positions investors and executives for the trading day. (Source: Bloomberg)
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Schwab US Dividend Equity ETF, which added 13,750,000 units, or a 0.5% increase week over week. Among the largest underlying components of SCHD, i
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Schwab US Dividend Equity ETF, which added 13,750,000 units, or a 0.5% increase week over week. Among the largest underlying components of SCHD, i
Robotics and automation have moved well beyond the trade‑show stage and into a real investment cycle. Companies across manufacturing, logistics, and fulfillment are deploying collaborative robots, machine‑vision systems, and autonomous mobile robots to address labor constraints and boost efficiency. DHL, UPS, and FedEx are already running large fleets of autonomous systems, and Amazon has more ......
Robotics and automation have moved well beyond the trade‑show stage and into a real investment cycle. Companies across manufacturing, logistics, and fulfillment are deploying collaborative robots, machine‑vision systems, and autonomous mobile robots to address labor constraints and boost efficiency. DHL, UPS, and FedEx are already running large fleets of autonomous systems, and Amazon has more ... The Humanoid Robot Boom Is Here. These 3 ETFs Capture the Entire Supply Chain
The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.36%. June E-mini S&P futures (ESM26 ) are up +0.38%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.36%. June E-mini S&P futures (ESM26 ) are up +0.38%, and June E-mini Nasdaq futures...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we